TXG10x Genomics, Inc.

TXG Stock Price, Valuation & Chart | 10x Genomics, Inc.

$61.650+1.67 (+2.78%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Medical - Healthcare Information Services TXG intrinsic value TXG calculated fair value vs price

Overview Financials Dividends Ratios

TXG Historical price chart

TXG Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization7.83B

PE Ratio-104.4

EPS-0.59

Trading Volume1.60M

Today's High/Low63.49/59.5

Dividend Yield0.00

52 Week High/Low66.94/11.16

Shares Outstanding126.96M

TXG Financial Statement

TXG Analyst ratings

TXG Analysis & performance metrics

TXG Company profile

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe,…

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions…

TXG Management team

Name

Position

Michael Schnall-LevinCTO

Founding Scientist & Chief Technology Officer

Eric S. Whitaker Esq.

Chief Legal Officer

Cassie Corneau

Manager of Investor Relations & Strategic Finance

Adam S. TaichCFO

Chief Financial Officer, Treasurer, Principal Financial Officer & Principal Accounting Officer

Mennah Moustafa

Chief Commercial Officer

Serge Saxonov Ph.D.CEO

Co-Founder, Chief Executive Officer & Director

Jim Goodrich

Chief of Global Operations

Jens DurruthyCTO

Associate Director of Product Management

Name

Position

Michael Schnall-LevinCTO

Founding Scientist & Chief Technology Officer

Eric S. Whitaker Esq.

Chief Legal Officer

Cassie Corneau

Manager of Investor Relations & Strategic Finance

Adam S. TaichCFO

Chief Financial Officer, Treasurer, Principal Financial Officer & Principal Accounting Officer

Mennah Moustafa

Chief Commercial Officer

Serge Saxonov Ph.D.CEO

Co-Founder, Chief Executive Officer & Director

Jim Goodrich

Chief of Global Operations

Jens DurruthyCTO

Associate Director of Product Management

Management Team

Michael Schnall-LevinCTO

Founding Scientist & Chief Technology Officer

Eric S. Whitaker Esq.

Chief Legal Officer

Cassie Corneau

Manager of Investor Relations & Strategic Finance

Adam S. TaichCFO

Chief Financial Officer, Treasurer, Principal Financial Officer & Principal Accounting Officer

Mennah Moustafa

Chief Commercial Officer

Serge Saxonov Ph.D.CEO

Co-Founder, Chief Executive Officer & Director

Jim Goodrich

Chief of Global Operations

Jens DurruthyCTO

Associate Director of Product Management

Management

Michael Schnall-LevinCTO

Founding Scientist & Chief Technology Officer

Eric S. Whitaker Esq.

Chief Legal Officer

Cassie Corneau

Manager of Investor Relations & Strategic Finance

Adam S. TaichCFO

Chief Financial Officer, Treasurer, Principal Financial Officer & Principal Accounting Officer

Mennah Moustafa

Chief Commercial Officer

Serge Saxonov Ph.D.CEO

Co-Founder, Chief Executive Officer & Director

Jim Goodrich

Chief of Global Operations

Jens DurruthyCTO

Associate Director of Product Management

Total 8 executives

TXG Frequently asked questions

What is 10x Genomics, Inc. (TXG) Stock Price?

Current stock price of 10x Genomics, Inc. (TXG) stock is $61.650. The stock price is +2.78% higher in the session. The intraday range can be seen from this page. Volume of 10x Genomics, Inc. (TXG) stock is 1.60M.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the 10x Genomics, Inc. (TXG) stock price going up or down today?

The stock price of 10x Genomics, Inc. (TXG) can change with earnings, company news, and overall market sentiment. 10x Genomics, Inc. operates in the Healthcare / Medical - Healthcare Information Services market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the 10x Genomics, Inc. stock expensive at its current price?

Whether 10x Genomics, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for TXG on this page is -104.49. EPS on this page is -0.59. Compare those figures with peers and growth expectations before deciding if the current 10x Genomics, Inc. price is justified.

How has the stock price of 10x Genomics, Inc. (TXG) performed historically?

Historical performance for 10x Genomics, Inc. (TXG) is shown on the price chart on this page. Review multi-period moves alongside volume to see how TXG reacted to past earnings and market events.

Should I buy 10x Genomics, Inc. (TXG) stock, at this price?

Buying 10x Genomics, Inc. (TXG) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.